en
Scientific article
English

Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?

Published inAmerican Journal of Medicine, vol. 130, no. 10, p. 1220.e17-1220.e22
Publication date2017
Abstract

The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembolism is unclear. We assessed whether the Factor V Leiden and the prothrombin G20210A mutation are associated with recurrent venous thromboembolism in elderly patients in a prospective multicenter cohort study.

Keywords
  • Aged
  • Aged, 80 and over
  • Factor V/genetics
  • Female
  • Humans
  • Male
  • Mutation/genetics
  • Prospective Studies
  • Prothrombin/genetics
  • Recurrence
  • Risk Factors
  • Thrombophilia/complications/genetics
  • Venous Thromboembolism/etiology/genetics
Citation (ISO format)
MÉAN, Marie et al. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? In: American Journal of Medicine, 2017, vol. 130, n° 10, p. 1220.e17–1220.e22. doi: 10.1016/j.amjmed.2017.05.026
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0002-9343
434views
0downloads

Technical informations

Creation01/31/2018 11:13:00 AM
First validation01/31/2018 11:13:00 AM
Update time03/15/2023 7:49:17 AM
Status update03/15/2023 7:49:17 AM
Last indexation01/17/2024 2:10:50 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack